This suggests that the risk of hypoglycemia with AMG 837 may be lower compared with that of insulin secretagogues such as sulfonylureas that stimulate insulin secretion regardless of ambient glucose levels [6]. The gene discussed is INS; the disease is Hypoglycemia.